 |
|
Niva Bupa Health Insurance, a newly listed company, experienced a mixed debut on the stock market. While the shares opened at a premium of around 5%, they failed to sustain these higher levels throughout the day. On the BSE, the stock opened at ₹78.50 and reached an intraday high of ₹80.94. Similarly, on the NSE, the share opened at ₹78.14 and hit an intraday peak of ₹81 within minutes of its debut. However, this initial enthusiasm proved short-lived, and the stock dipped significantly, reaching an intraday low of ₹73.51 on the NSE and ₹73.60 on the BSE.
Despite the initial dip, experts are generally optimistic about the long-term prospects of Niva Bupa Health Insurance. They highlight factors like the growing middle class, rising demand for healthcare, and the company's strong parent backing as indicators of its future growth potential. The interpenetration of health insurance in India, coupled with increasing consumer awareness and medical inflation, is expected to further fuel the company's expansion.
While advocating for long-term holding, experts stress the importance of monitoring the company's performance closely. Investors are advised to remain vigilant about the company's financial results, market conditions, and overall trajectory. New investors are recommended to wait for a clearer picture of Niva Bupa's future before making an investment decision. Despite the volatility and competition in the sector, those allotted shares in the IPO are encouraged to hold them for the long term. Non-allottees are advised to consider buying shares at around the issue price or during dips, with a focus on long-term gains.
Source: Niva Bupa Health Insurance share price dips after positive debut. Buy, sell or hold?